S&P 500   3,635.00 (+0.15%)
DOW   29,880.25 (+0.03%)
QQQ   298.95 (+0.90%)
AAPL   116.80 (+0.66%)
MSFT   215.15 (+0.60%)
FB   277.05 (+0.53%)
GOOGL   1,783.18 (+1.08%)
AMZN   3,200.99 (+0.50%)
TSLA   591.69 (+3.08%)
NVDA   528.80 (-0.11%)
BABA   276.06 (-0.60%)
CGC   27.13 (+0.97%)
GE   10.41 (-0.86%)
MU   64.14 (+1.12%)
AMD   86.88 (+0.20%)
T   28.98 (-0.03%)
NIO   53.58 (-0.20%)
F   9.09 (+0.11%)
ACB   8.73 (+0.23%)
NFLX   489.61 (+0.95%)
GILD   59.80 (+0.50%)
BA   217.05 (-0.26%)
DIS   147.62 (-0.99%)
S&P 500   3,635.00 (+0.15%)
DOW   29,880.25 (+0.03%)
QQQ   298.95 (+0.90%)
AAPL   116.80 (+0.66%)
MSFT   215.15 (+0.60%)
FB   277.05 (+0.53%)
GOOGL   1,783.18 (+1.08%)
AMZN   3,200.99 (+0.50%)
TSLA   591.69 (+3.08%)
NVDA   528.80 (-0.11%)
BABA   276.06 (-0.60%)
CGC   27.13 (+0.97%)
GE   10.41 (-0.86%)
MU   64.14 (+1.12%)
AMD   86.88 (+0.20%)
T   28.98 (-0.03%)
NIO   53.58 (-0.20%)
F   9.09 (+0.11%)
ACB   8.73 (+0.23%)
NFLX   489.61 (+0.95%)
GILD   59.80 (+0.50%)
BA   217.05 (-0.26%)
DIS   147.62 (-0.99%)
S&P 500   3,635.00 (+0.15%)
DOW   29,880.25 (+0.03%)
QQQ   298.95 (+0.90%)
AAPL   116.80 (+0.66%)
MSFT   215.15 (+0.60%)
FB   277.05 (+0.53%)
GOOGL   1,783.18 (+1.08%)
AMZN   3,200.99 (+0.50%)
TSLA   591.69 (+3.08%)
NVDA   528.80 (-0.11%)
BABA   276.06 (-0.60%)
CGC   27.13 (+0.97%)
GE   10.41 (-0.86%)
MU   64.14 (+1.12%)
AMD   86.88 (+0.20%)
T   28.98 (-0.03%)
NIO   53.58 (-0.20%)
F   9.09 (+0.11%)
ACB   8.73 (+0.23%)
NFLX   489.61 (+0.95%)
GILD   59.80 (+0.50%)
BA   217.05 (-0.26%)
DIS   147.62 (-0.99%)
S&P 500   3,635.00 (+0.15%)
DOW   29,880.25 (+0.03%)
QQQ   298.95 (+0.90%)
AAPL   116.80 (+0.66%)
MSFT   215.15 (+0.60%)
FB   277.05 (+0.53%)
GOOGL   1,783.18 (+1.08%)
AMZN   3,200.99 (+0.50%)
TSLA   591.69 (+3.08%)
NVDA   528.80 (-0.11%)
BABA   276.06 (-0.60%)
CGC   27.13 (+0.97%)
GE   10.41 (-0.86%)
MU   64.14 (+1.12%)
AMD   86.88 (+0.20%)
T   28.98 (-0.03%)
NIO   53.58 (-0.20%)
F   9.09 (+0.11%)
ACB   8.73 (+0.23%)
NFLX   489.61 (+0.95%)
GILD   59.80 (+0.50%)
BA   217.05 (-0.26%)
DIS   147.62 (-0.99%)
Log in
NASDAQ:VKTX

Viking Therapeutics SEC Filings & 10K Form

$6.69
+0.33 (+5.19 %)
(As of 11/27/2020 12:02 PM ET)
Add
Compare
Today's Range
$6.43
Now: $6.69
$6.71
50-Day Range
$5.30
MA: $5.97
$6.42
52-Week Range
$3.26
Now: $6.69
$8.87
Volume16,955 shs
Average Volume1.37 million shs
Market Capitalization$488.05 million
P/E RatioN/A
Dividend YieldN/A
Beta2.02

SEC Filings

Viking Therapeutics (NASDAQ:VKTX) SEC Filings

DateFilerForm TypeView
10/28/2020
4:00 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2020
3:10 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2020
4:21 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2020
4:18 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2020
4:19 PM
LIGAND PHARMACEUTICALS INC (Filed by)
Viking Therapeutics (Subject)
Form SC 13D/A
08/28/2020
4:11 PM
LIGAND PHARMACEUTICALS INC (Reporting)
Viking Therapeutics (Issuer)
Form 4/A
08/27/2020
6:06 PM
LIGAND PHARMACEUTICALS INC (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
4:54 PM
FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
3:30 PM
Viking Therapeutics (Filer)
Form DEFA14A
04/30/2020
4:01 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/06/2020
3:45 PM
Viking Therapeutics (Filer)
Form DEFA14A
04/03/2020
4:47 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
3:20 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
3:40 PM
Viking Therapeutics (Filer)
Form CT ORDER
02/07/2020
10:34 AM
FMR LLC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
02/06/2020
8:10 AM
BlackRock Inc. (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
01/21/2020
4:39 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2020
4:35 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
7:03 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
7:01 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
7:01 PM
Viking Therapeutics (Issuer)
Webster Stephen W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
6:59 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
6:59 PM
FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
6:57 PM
MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
6:55 PM
Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
6:54 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
3:31 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
6:15 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2019
5:27 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2019
3:02 PM
ArrowMark Colorado Holdings LLC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
08/02/2019
4:59 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
4:16 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
3:24 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2019
3:20 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
3:15 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2019
3:46 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
4:09 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/10/2019
12:50 PM
STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
04/05/2019
3:40 PM
Viking Therapeutics (Filer)
Form DEFA14A
04/05/2019
3:25 PM
Viking Therapeutics (Filer)
Form DEF 14A
03/13/2019
5:54 PM
Viking Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/13/2019
4:01 PM
Viking Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2019
3:12 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
6:53 AM
ArrowMark Colorado Holdings LLC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G
02/13/2019
11:08 AM
FMR LLC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
02/13/2019
9:19 AM
STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
Form SC 13G
01/22/2019
6:13 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2019
6:13 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:35 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:33 PM
Masamune Hiroko (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:31 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:28 PM
Viking Therapeutics (Issuer)
Webster Stephen W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:27 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:26 PM
FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:22 PM
MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:20 PM
Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2018
4:03 PM
LIGAND PHARMACEUTICALS INC (Filed by)
Viking Therapeutics (Subject)
Form SC 13D/A
11/07/2018
4:01 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2018
9:04 AM
FMR LLC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G
09/27/2018
8:25 PM
LIGAND PHARMACEUTICALS INC (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2018
3:16 PM
Viking Therapeutics (Filer)
Form 424B5
09/21/2018
5:05 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2018
3:27 PM
Viking Therapeutics (Filer)
Form 424B5
09/18/2018
6:10 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
4:11 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2018
11:15 PM
Viking Therapeutics (Filer)
Form EFFECT
07/11/2018
4:02 PM
Viking Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/03/2018
4:25 PM
Masamune Hiroko (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
4:22 PM
Masamune Hiroko (Reporting)
Viking Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/12/2018
6:10 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2018
4:13 PM
Viking Therapeutics (Filer)
Form 424B5
06/07/2018
12:41 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2018
8:04 AM
Viking Therapeutics (Filer)
Form S-3MEF
06/06/2018
3:11 PM
Viking Therapeutics (Filer)
Form 424B5
05/31/2018
6:04 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
6:03 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
6:02 PM
Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
5:59 PM
Viking Therapeutics (Issuer)
Webster Stephen W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
5:57 PM
MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2018
4:02 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2018
7:37 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2018
7:37 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2018
3:38 PM
Viking Therapeutics (Filer)
Form DEFA14A
04/06/2018
3:15 PM
Viking Therapeutics (Filer)
Form DEF 14A
03/07/2018
4:16 PM
Viking Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2018
4:11 PM
Viking Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2018
3:14 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2018
3:15 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2018
8:30 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2018
3:17 PM
Viking Therapeutics (Filer)
Form 424B5
01/23/2018
4:42 PM
MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2018
4:41 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2018
11:15 PM
Viking Therapeutics (Filer)
Form EFFECT
01/16/2018
4:17 PM
Viking Therapeutics (Filer)
Form 424B3
01/09/2018
4:28 PM
Viking Therapeutics (Filer)
Form S-1/A
12/20/2017
4:21 PM
Viking Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/19/2017
1:23 PM
Farwell Grosvenor Nicholas (Filed by)
Viking Therapeutics (Subject)
Form SC 13G
12/18/2017
8:56 AM
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Viking Therapeutics (Subject)
Form SC 13G
12/11/2017
3:25 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2017
3:38 PM
Viking Therapeutics (Filer)
Form 424B5
This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.